Perioperative Nivolumab and Chemotherapy in Non-Small-Cell Lung Cancer

被引:2
|
作者
Verma, Saurav [1 ]
Vincent, Mark [1 ]
Breadner, Daniel [1 ]
机构
[1] London Reg Canc Program, London, ON, Canada
来源
NEW ENGLAND JOURNAL OF MEDICINE | 2023年 / 389卷 / 16期
关键词
D O I
10.1056/NEJMc2310641
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1534 / 1534
页数:1
相关论文
共 50 条
  • [1] Perioperative Nivolumab and Chemotherapy in Stage III Non-Small-Cell Lung Cancer
    Provencio, Mariano
    Nadal, Ernest
    Gonzalez-Larriba, Jose L.
    Martinez-Marti, Alex
    Bernabe, Reyes
    Bosch-Barrera, Joaquim
    Casal-Rubio, Joaquin
    Calvo, Virginia
    Insa, Amelia
    Ponce, Santiago
    Reguart, Noemi
    de Castro, Javier
    Mosquera, Joaquin
    Cobo, Manuel
    Aguilar, Andres
    Vivanco, Guillermo Lopez
    Camps, Carlos
    Lopez-Castro, Rafael
    Moran, Teresa
    Barneto, Isidoro
    Rodriguez-Abreu, Delvys
    Serna-Blasco, Roberto
    Benitez, Raquel
    Aguado de la Rosa, Carlos
    Palmero, Ramon
    Hernando-Trancho, Florentino
    Martin-Lopez, Javier
    Cruz-Bermudez, Alberto
    Massuti, Bartomeu
    Romero, Atocha
    NEW ENGLAND JOURNAL OF MEDICINE, 2023, 389 (06): : 504 - 513
  • [2] Nivolumab in Nonsquamous Non-Small-Cell Lung Cancer
    Hasegawa, Takahiro
    Uno, Hajime
    Wei, Lee-Jen
    NEW ENGLAND JOURNAL OF MEDICINE, 2016, 374 (05): : 492 - 492
  • [3] Perioperative Nivolumab in non-small cell Lung Cancer
    Lorenz, Judith
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2024, 149 (18) : 1065 - 1066
  • [4] Chemotherapy for non-small-cell lung cancer
    Satoh, H
    Sekizawa, K
    LANCET, 2001, 358 (9289): : 1270 - 1271
  • [5] Nivolumab plus Ipilimumab in Non-Small-Cell Lung Cancer
    Bersanelli, Melissa
    Tiseo, Marcello
    Banna, Giuseppe L.
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (09): : 874 - 875
  • [6] Effect and biomarker of Nivolumab for non-small-cell lung cancer
    Wang, Li
    Zhao, Deze
    Qin, Kang
    Ul Rehman, Faisal
    Zhang, Xiaochun
    BIOMEDICINE & PHARMACOTHERAPY, 2019, 117
  • [7] Nivolumab plus ipilimumab in non-small-cell lung cancer
    Reck, Martin
    Borghaei, Hossein
    O'Byrne, Kenneth J.
    FUTURE ONCOLOGY, 2019, 15 (19) : 2287 - 2302
  • [8] Nivolumab in non-small-cell lung cancer with EGFR mutation
    Yoshida, H.
    Kim, Y. H.
    Ozasa, H.
    Nagai, H.
    Sakamori, Y.
    Tsuji, T.
    Nomizo, T.
    Yasuda, Y.
    Funazo, T.
    Hirai, T.
    ANNALS OF ONCOLOGY, 2018, 29 (03) : 777 - 778
  • [9] Nivolumab for squamous-cell non-small-cell lung cancer
    Yaqub, Farhat
    LANCET ONCOLOGY, 2015, 16 (07): : E319 - E319
  • [10] Preoperative chemotherapy for non-small-cell lung cancer
    Hanna, Gerard G.
    Siva, Shankar
    Plumridge, Nikki
    Solomon, Benjamin
    Ball, David L.
    LANCET, 2014, 384 (9939): : 232 - 233